Abstract:The replacement histone variant H2AX senses DNA double-strand breaks (DSBs) and recruits characteristic sets of proteins at its phosphorylated (gamma-H2AX) foci for concurrent DNA repair. We reasoned that the H2AX interaction network, or interactome, formed in the tumor-associated DNA DSB environment such as in hepatocellular carcinoma (HCC) cells, where preneoplastic lesions frequently occur, is indicative of HCC pathogenic status. By using an in vivo dual-tagging quantitative proteomic method, we identified 102 H2AX-specific interacting partners in HCC cells that stably expressed FLAG-tagged H2AX at close to the endogenous level. Using bioinformatics tools for data-dependent network analysis, we further found binary relationships among these interactors in defined pathway modules, implicating H2AX in a multifunctional role of coordinating a variety of biological pathways involved in DNA damage recognition and DNA repair, apoptosis, nucleic acid metabolism, Ca(2+)-binding signaling, cell cycle, etc. Furthermore, our observations suggest that these pathways interconnect through key pathway components or H2AX interactors. The physiological accuracy of our quantitative proteomic approach in determining H2AX-specific interactors was evaluated by both coimmunoprecipitation/ immunoblotting and confocal colocalization experiments performed on HCC cells. Due to their involvement in diverse functions, the H2AX interactors involved in different pathway modules, such as Poly(ADP-ribose) polymerase 1, 14-3-3 zeta, coflin 1, and peflin 1, were examined for their relative H2AX binding affinities in paired hepatocytes and HCC cells. Treatment with the DSB-inducing agent bleomycin enhanced binding of these proteins to H2AX, suggesting an active role of H2AX in coordinating the functional pathways of each protein in DNA damage recognition and repair.

Mass Spectrometric Proteomics Reveals That Nuclear Protein Positive Cofactor PC4 Selectively Binds to Cross-Linked DNA by a Trans-Platinum Anticancer Complex

HDX-MS Combining Molecular Dynamics Simulation Reveals Structural Basis of Transcriptional Coactivator PC4 Binding to a Platinum Crosslinked Double-Stranded DNA

Proteomic Strategy for Identification of Proteins Responding to Cisplatin-Damaged DNA.

Nuclear proteome analysis of cisplatin-treated HeLa cells

Proteomic Analysis of Cisplatin- and Oxaliplatin-Induced Phosphorylation in Proteins Bound to Pt-DNA Adducts.

Click Chemistry-Based Force Spectroscopy Revealed Enhanced Binding Dynamics of Phosphorylated HMGB1 to Cisplatin-DNA

Hmgb1 Bound To Cisplatin-Dna Adducts Undergoes Extensive Acetylation And Phosphorylation In Vivo

Cisplatin treatment leads to changes in nuclear protein and microRNA expression

Mass Spectrometry-Based Quantification of the Cellular Response to Ultraviolet Radiation in HeLa Cells.

Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action

The role of carrier ligands of platinum(II) anticancer complexes in the protein recognition of Pt–DNA adducts

Nuclear Proteome Analysis of Benzo(a)pyrene-Treated HeLa Cells.

Chemoproteomic profiling unveils binding and functional diversity of endogenous proteins that interact with endogenous triplex DNA

PC4-mediated Ku complex PARylation facilitates NHEJ-dependent DNA damage repair

Functional Characterization of TIP60 Sumoylation in UV-irradiated DNA Damage Response.

Dna Cross-Linking Patterns Induced by an Antitumor-Active Trinuclear Platinum Complex and Comparison with Its Dinuclear Analogue

The Role of Bridging Ligands in Determining DNA-binding Ability and Cross-Linking Patterns of Dinuclear Platinum(ii) Antitumour Complexes.

Integrated Global Proteomic and Phosphoproteomic Analysis of Cisplatin-Induced Apoptosis in A549 Cells

Molecular targets of cisplatin in HeLa cells explored through competitive activity-based protein profiling strategy

Proteomic Dissection of Cell Type-Specific H2AX-interacting Protein Complex Associated with Hepatocellular Carcinoma.

Base-Resolution Analysis of Cisplatin-Dna Adducts at the Genome Scale